Home LiteratureArticle Details
PMID: 6180785 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Specific factor VIII-related antigen fragmentation: an in vivo and in vitro phenomenon.

Blood ·Vol. 60 ·No. 4 ·1982-10-00 ·Pages 930-9

Montgomery RR, Johnson J

Abstract

Factor VIII concentrates have been shown to have reduced ability to correct the bleeding time defect in von Willebrand's disease and to have abnormal mobility of their VIIIR:Ag on crossed immunoelectrophoresis. This report concerns the partial characterization of a fragment of VIIIR:Ag that lacks some of the normal antigenic determinants present on VIIIR:Ag. It is present in commercial factor VIII concentrates, but not in cryoprecipitate, and is recovered from the plasma of hemophilic patients who have been infused with these concentrates. The fragment is also produced during disseminated intravascular coagulation. Although it has a similar mobility on SDS agarose electrophoresis to the smallest multimer of VIIIR:Ag, they are not immunologically identical.

MeSH Terms
Chemical Fractionation Disseminated Intravascular Coagulation/blood Epitopes Factor VIII/analysis,immunology,isolation & purification,therapeutic use Hemophilia A/drug therapy Humans Immune Sera Immunoelectrophoresis, Two-Dimensional von Willebrand Diseases/drug therapy
Chemicals
Epitopes Immune Sera Factor VIII
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Montgomery R R
Johnson J
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
1982-10-00
Pages
930-9
Language
English
Region
United States
NLM ID
7603509
Subset
IM
Grants
NHLBI NIH HHS · HL 21730 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com